Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (VKTX)
NASDAQ:VKTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -292.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -150.92M | $ -100.83M | $ -70.36M | $ -55.68M | $ -42.66M |
| EBITDA | $ -150.57M | $ -100.53M | $ -70.06M | $ -55.39M | $ -39.11M |
| Net Income | $ -109.96M | $ -85.89M | $ -68.87M | $ -54.99M | $ -39.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 902.61M | $ 362.08M | $ 155.49M | $ 202.10M | $ 248.39M |
| Total Assets | $ 908.32M | $ 368.49M | $ 168.53M | $ 210.66M | $ 256.50M |
| Total Debt | $ 1.12M | $ 1.26M | $ 1.56M | $ 29.00K | $ 359.00K |
| Net Debt | $ -25.56M | $ -54.26M | $ -35.07M | $ -26.34M | $ -28.76M |
| Total Liabilities | $ 28.04M | $ 20.07M | $ 23.21M | $ 8.78M | $ 12.16M |
| Stockholders' Equity | $ 880.28M | $ 348.42M | $ 145.32M | $ 201.88M | $ 244.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -87.79M | $ -73.38M | $ -48.40M | $ -47.59M | $ -21.78M |
| Operating Cash Flow | $ -87.79M | $ -73.38M | $ -48.40M | $ -47.59M | $ -21.78M |
| Investing Cash Flow | $ -553.37M | $ -179.09M | $ 54.75M | $ 37.96M | $ 41.57M |
| Financing Cash Flow | $ 612.46M | $ 271.38M | $ 4.16M | $ 6.88M | $ 950.00K |